Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)
Islet Autoantibody Early Detection in At-risk Children/Adolescents to Predict Type 1 Diabetes: a Cohort Study in Gulf Countries
Sanofi
3,500 participants
Dec 17, 2025
INTERVENTIONAL
Conditions
Summary
The aim of this research is to identify pre-symptomatic Type 1 Diabetes (T1D) in young children and adolescents who have first degree relatives with T1D. This protocol has been developed to address the growing need for standardized T1D screening, monitoring, and data collection in alignment with international recommendations. The study's estimated duration is 13 months and will consist of two visits: Visit 1 (screening visit) and Visit 2 (confirmatory visit).
Eligibility
Inclusion Criteria3
- Children and adolescents, age 1.5 years to 18 years
- First degree relatives of T1D probands
- Parent or legal guardian signing an informed consent
Exclusion Criteria4
- Already developed clinical overt T1D
- Known diabetes of any kind (type 1, type 2, Maturity Onset Diabetes of the Young - MODY)
- Have a previous history of being treated with insulin
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Interventions
It consists of prospective blood sample collection from children, adolescents and first-degree relatives of T1D probands. Study without any Investigational Medicinal Product (IMP) administration.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07038473